相关实验视频

Updated: Jul 24, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

在白血病患者中对H-ARS严重性预测基因的验证 - 跨物种比较,挑战和承诺

Daniel Schwanke¹, Marco Valente², Patrick Ostheim¹

¹Bundeswehr Institute of Radiobiology, Munich, Germany.

International journal of radiation biology

|January 16, 2024

概括

研究了白血病患者的基因表达,以预测辐射综合征的严重程度. 虽然一些基因表现有前途,但验证受到白血病类型和RNA数量的限制,这凸显了改善样本选择和敏感测量技术的需要.

科学领域:

辐射生物学辐射生物学
基因组学就是基因组学.
血液学血液学血液学

背景情况:

血液性急性辐射综合征 (H-ARS) 严重程度的预测对于临床管理至关重要.
之前的研究发现了29个H-ARS预测基因,其中4个显示出有前途.
在人类白血病患者中验证这些基因对于临床适用性至关重要.

研究的目的:

为了进一步验证先前识别的H-ARS严重性预测基因在更大的全身照射白血病患者队列中.
评估使用基因表达分析进行生物对比和H-ARS预测在人类受试者的可行性.

主要方法:

从10名白血病患者中采集了外周血液样本,这些患者接受了全身分片辐射 (TBI).
31个基因的基因表达,包括四个有前途的候选人,使用定量逆转录PCR (qRT-PCR) 用低密度阵列 (LDA) 和96井格式进行了评估.
计算了基因表达相对于辐射前水平的折叠变化.

主要成果:

在5名急性淋巴细胞白血病 (ALL) 和非霍奇金淋巴瘤 (NHL) 患者中,基因表达概况成功,但由于缺乏RNA,急性髓性白血病 (AML) 患者没有成功.
使用LDA验证了13个基因,但最有前途的4个基因表现不一致或无法检测到.
FDXR,DDB2和POU2AF1在和人类白血病患者之间显示了特定物种或类似的调节模式,23个基因中的16个显示了保留的表达变化.

结论:

对H-ARS严重性预测的鉴定基因在ALL但不是AML患者中得到验证,其中包括白血病类型,RNA数量和抑制的基因表达变化等限制.
方法上的挑战需要改进样本选择,包括血液细胞计数和基于光的RNA量化.
对于基线表达较低的候选基因,建议采用更敏感的96井格式.

关键词:

这是ARS.ARS.DDB2 DDB2 在线播放美国FDXRR 国家卫生健康计划 (NHP)在POU2AF1AF1中.辐射辐射辐射辐射辐射辐射辐射在WNT3中使用WNT3.生物测量仪生物测量仪预测临床结果的预测.基因表达的基因表达方式这种白血病是白血病.病人的病人的病人的病.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

相关概念视频

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...